Key result
Persistent AF shows no difference in post-ablation recurrence or hospitalization compared with paroxysmal AF.
Why the study?
The independent impact of AF type on long-term prognosis after catheter ablation remains debated.
Does persistent atrial fibrillation compared with paroxysmal atrial fibrillation independently increase the long-term risk of all-cause hospitalization, AF recurrence (after the 3-month blanking period), stroke/bleeding, or heart failure after first-time catheter radiofrequency ablation?
Cohort (n=365)
No
Does persistent atrial fibrillation compared with paroxysmal atrial fibrillation independently increase the long-term risk of all-cause hospitalization, AF recurrence (after the 3-month blanking period), stroke/bleeding, or heart failure after first-time catheter radiofrequency ablation?
Apparent two-fold higher post-ablation recurrence rates in persistent versus paroxysmal AF were entirely driven by early recurrences within the 3-month blanking period (59% vs 29% of recurrences), with no differences in late recurrence or clinical outcomes after blanking-period exclusion and propensity adjustment.
Background Whether atrial fibrillation (AF) type independently determines long-term prognosis after catheter ablation remains debated. We compared outcomes between paroxysmal and persistent AF after ablation using propensity score matching (PSM) with inverse probability of treatment weighting (IPTW). Methods This single-center retrospective cohort included 365 patients (239 paroxysmal, 126 persistent) undergoing first-time ablation (2016–2025). Outcomes were all-cause hospitalization, AF recurrence, a composite stroke/bleeding outcome, and heart failure (HF). PSM (1:1, exact on HF history, caliper 0.1) yielded 65 matched pairs; analyses comprised pair-clustered Cox models, restricted mean survival time, IPTW, multivariable adjustment, FDR-corrected subgroups, and LASSO-Cox. Follow-up was protocol-limited to 5 years; no deaths occurred. Results Recurrences within the 3-month blanking period were excluded: 21 of 50 (42%), disproportionately frequent in persistent AF (13/22, 59% vs 8/28, 29%). No outcome differed between groups after matching (hospitalization HR 0.948, 95% CI 0.504–1.784; recurrence 0.411, 0.079–2.140; stroke/bleeding 2.162, 0.186–25.109; HF 0.676, 0.109–4.173). Including blanking-period events produced an apparent two-fold higher recurrence risk in persistent AF (crude HR 1.758, P = 0.049; IPTW HR 2.054–2.223, P < 0.05) that disappeared after exclusion (crude HR 1.020, P = 0.961; IPTW HR 1.147–1.215, P > 0.6). Subgroup findings were exploratory and did not survive FDR correction. Conclusions After applying the consensus blanking-period definition, paroxysmal and persistent AF showed no differences in hospitalization, recurrence, stroke/bleeding, or HF across all analytic approaches; apparent recurrence differences were entirely attributable to blanking-period events, disproportionately frequent in persistent AF. Findings are limited by small event counts and month-level follow-up precision.
No takes yet. Share an insight, caveat, or question.
Li¹ et al. (2026) conducted a cohort in Paroxysmal or persistent atrial fibrillation undergoing first-time catheter radiofrequency ablation (n=365). Persistent atrial fibrillation phenotype undergoing first-time catheter radiofrequency ablation vs. Paroxysmal atrial fibrillation phenotype undergoing first-time catheter radiofrequency ablation was evaluated on Atrial fibrillation recurrence (documented atrial arrhythmia lasting >=30 seconds after the 3-month blanking period) in the propensity-matched cohort (HR 0.411, 95% CI 0.079–2.140, p=0.291). Persistent vs paroxysmal AF showed no difference in post-ablation recurrence after blanking-period exclusion (matched HR 0.411, 95% CI 0.079-2.140) or hospitalization (HR 0.948).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: